Literature DB >> 7785978

Plasmid-mediated dissemination of the metallo-beta-lactamase gene blaIMP among clinically isolated strains of Serratia marcescens.

H Ito1, Y Arakawa, S Ohsuka, R Wacharotayankun, N Kato, M Ohta.   

Abstract

The distribution of strains producing metallo-beta-lactamase among 105 strains of Serratia marcescens was investigated. All of these strains were isolated in seven general hospitals located in Aichi Prefecture, Japan, from April to May 1993. Southern hybridization analysis suggested that four S. marcescens strains, AK9373, AK9374, AK9385, and AK9391, had a metallo-beta-lactamase genes similar to the blaIMP gene found by our laboratory (E. Osano, Y. Arakawa, R. Wacharotayankun, M. Ohta, T. Horii, H. Ito, F. Yoshimura, and N. Kato, Antimicrob. Agents Chemother. 38:71-78, 1994), and these four strains showed resistance to carbapenems as well as to the other broad-spectrum beta-lactams. In particular, strains AK9373, AK9374, and AK9391 showed an extraordinarily high-level resistance to imipenem (MICs, > or = 64 micrograms/ml), whereas strain AK9385 demonstrated moderate imipenem resistance (MIC, 8 micrograms/ml). The imipenem resistance of AK9373 was transferred to Escherichia coli CSH2 by conjugation with a frequency of 10(-5). The DNA probe of the blaIMP gene hybridized to a large plasmid (approximately 120 kb) transferred into the E. coli transconjugant as well as to the large plasmids harbored by AK9373. On the other hand, although we failed in the conjugational transfer of imipenem resistance from strains AK9374, AK9385, and AK9391 to E. coli CSH2, imipenem resistance was transferred from these strains to E. coli HB101 by transformation. A plasmid (approximately 25 kb) was observed in each transformant which acquired imipenem resistance. The amino acid sequence at the N terminus of the enzyme purified from strain AK9373 was identical to that of the metallo-beta-lactamase IMP-1. In contrast, strains ES9348, AK9386, and AK93101, which were moderately resistant to imipenem (MICs, > or = 4 to < or = 8 micrograms/ml), had no detectable blaIMP gene. As a conclusion, 19% of clinically isolated S. marcescens strains in Aichi Prefecture, Japan, in 1993 were resistant to imipenem (MICs, > or = 2 micrograms/ml), and strains which showed high-level imipenem resistance because of acquisition of a plasmid-mediated blaIMP-like metallo-beta-lactamase gene had already proliferated as nosocomial infections, at least in a general hospital.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7785978      PMCID: PMC162636          DOI: 10.1128/AAC.39.4.824

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  35 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Emergence of resistance to imipenem during therapy for Pseudomonas aeruginosa infections.

Authors:  J P Quinn; E J Dudek; C A DiVincenzo; D A Lucks; S A Lerner
Journal:  J Infect Dis       Date:  1986-08       Impact factor: 5.226

3.  In vitro activity against aerobic and anaerobic gram-positive and gram-negative bacteria and beta-lactamase stability of RS-533, a novel carbapenem.

Authors:  H C Neu; N X Chin; G Saha; P Labthavikul
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

4.  Domains involved in osmoregulation of the ompF gene in Escherichia coli.

Authors:  K Inokuchi; M Itoh; S Mizushima
Journal:  J Bacteriol       Date:  1985-11       Impact factor: 3.490

5.  Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors.

Authors:  C Yanisch-Perron; J Vieira; J Messing
Journal:  Gene       Date:  1985       Impact factor: 3.688

6.  Close evolutionary relationship between the chromosomally encoded beta-lactamase gene of Klebsiella pneumoniae and the TEM beta-lactamase gene mediated by R plasmids.

Authors:  Y Arakawa; M Ohta; N Kido; Y Fujii; T Komatsu; N Kato
Journal:  FEBS Lett       Date:  1986-10-20       Impact factor: 4.124

7.  Contribution of enzymatic properties, cell permeability, and enzyme expression to microbiological activities of beta-lactams in three Bacteroides fragilis isolates that harbor a metallo-beta-lactamase gene.

Authors:  B A Rasmussen; Y Yang; N Jacobus; K Bush
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

8.  Beta-lactamase-mediated imipenem resistance in Bacteroides fragilis.

Authors:  G J Cuchural; M H Malamy; F P Tally
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

9.  Sequence of the Citrobacter freundii OS60 chromosomal ampC beta-lactamase gene.

Authors:  F Lindberg; S Normark
Journal:  Eur J Biochem       Date:  1986-05-02

10.  Chromosomal beta-lactamases of Enterobacter cloacae are responsible for resistance to third-generation cephalosporins.

Authors:  A H Seeberg; R M Tolxdorff-Neutzling; B Wiedemann
Journal:  Antimicrob Agents Chemother       Date:  1983-06       Impact factor: 5.191

View more
  73 in total

1.  Plasmid-encoded metallo-beta-lactamase (IMP-6) conferring resistance to carbapenems, especially meropenem.

Authors:  H Yano; A Kuga; R Okamoto; H Kitasato; T Kobayashi; M Inoue
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

2.  Identification of residues critical for metallo-beta-lactamase function by codon randomization and selection.

Authors:  I C Materon; T Palzkill
Journal:  Protein Sci       Date:  2001-12       Impact factor: 6.725

3.  Identification of a plasmid encoding SHV-12, TEM-1, and a variant of IMP-2 metallo-beta-lactamase, IMP-8, from a clinical isolate of Klebsiella pneumoniae.

Authors:  J J Yan; W C Ko; J J Wu
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

Review 4.  Comparative pharmacokinetics of the carbapenems: clinical implications.

Authors:  J W Mouton; D J Touzw; A M Horrevorts; A A Vinks
Journal:  Clin Pharmacokinet       Date:  2000-09       Impact factor: 6.447

5.  Detection of carbapenemase-producing Acinetobacter baumannii in a hospital.

Authors:  A Takahashi; S Yomoda; I Kobayashi; T Okubo; M Tsunoda; S Iyobe
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

6.  A new TEM-derived extended-spectrum beta-lactamase (TEM-91) with an R164C substitution at the omega-loop confers ceftazidime resistance.

Authors:  Hiroshi Kurokawa; Naohiro Shibata; Yohei Doi; Keigo Shibayama; Kazunari Kamachi; Tetsuya Yagi; Yoshichika Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

7.  In vitro evolution predicts that the IMP-1 metallo-beta-lactamase does not have the potential to evolve increased activity against imipenem.

Authors:  Barry G Hall
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

Review 8.  Carbapenemases: the versatile beta-lactamases.

Authors:  Anne Marie Queenan; Karen Bush
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

9.  Molecular dynamic simulations of the metallo-beta-lactamase from Bacteroides fragilis in the presence and absence of a tight-binding inhibitor.

Authors:  Freddie R Salsbury; Michael W Crowder; Stephen F Kingsmore; James J A Huntley
Journal:  J Mol Model       Date:  2008-11-28       Impact factor: 1.810

10.  Molecular characterization of class 3 integrons from Delftia spp.

Authors:  Hai Xu; Julian Davies; Vivian Miao
Journal:  J Bacteriol       Date:  2007-06-15       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.